Dr. Michelle Hwang, MD

Dr. Hwang practices at Torrance Emerald Dialysis in Torrance, California.

Dr. Hwang's NPI, 1134503337, was assigned on July 17, 2015. Dr. Hwang graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2015. Dr. Hwang holds California license A144799.

Dr. Hwang's primary practice is Torrance Emerald Dialysis, at 3291 Skypark Dr, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 214-1715.

Dr. Hwang's primary practice is Torrance Emerald Dialysis in Torrance, California. Dr. Hwang is also affiliated with Torrance Memorial Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Hwang to 3 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hwang practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hwang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hwang is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hwang is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, gout, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Hwang treats.

CMS data shows 2,833 Medicare services from Dr. Hwang across 9 procedure codes in 2024, for 538 Medicare patients. Medicare paid $242,650 for them.

CMS counts 538 Medicare patients who saw Dr. Hwang in 2024. The largest group is 75 to 84, with 198 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hwang's median patient age at 66, with 46% women.

In 2024, Dr. Hwang wrote 1,422 Medicare Part D claims for 283 patients. 88% of them were for generic drugs. CMS names the drug for 1,147 of them, across 27 drugs with 11 or more claims each, at $140,877 in total drug cost. In 2023, CMS named 1,055 claims across 28 drugs.

Dr. Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hwang as offering telehealth.

CMS Open Payments shows 39 general payments to Dr. Hwang from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. GlaxoSmithKline, LLC. paid the most, $6,142.

Dr. Hwang graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2015.

Dr. Hwang is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.